Experts in the discovery and development of small molecule medicines for immuno-inflammatory diseases

C4X Discovery (C4XD) is a pioneering Drug Discovery company, combining scientific expertise with cutting-edge technologies to efficiently deliver world leading medicines. We have a highly valuable and differentiated approach to Drug Discovery through our enhanced molecular design and patient stratification capabilities, generating small molecule drug candidates across multiple disease indications focused on immuno-inflammation. Our internal portfolio of discovery programmes is advancing towards clinical trials with one programme in the pre-clinical candidate selection stage. We have two commercially partnered programmes with Sanofi and AstraZeneca, and one clinical stage candidate which has been acquired by Indivior.

Inspirational leadership underpinned by decades of Drug Discovery and industry expertise